Prostate Cancer
3 competing products in clinical development for Prostate Cancer.
Pipeline by Phase
Phase 1/21
Phase 21
Phase 2/31
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Abemaciclib + Placebo + Abiraterone acetate + Prednisone | Eli Lilly | Phase 2/3 | Active | 65 |
| Pemetrexed | Eli Lilly | Phase 2 | Completed | 52 |
| NBTXR3 activated by IMRT only + NBTXR3 activated by Brachytherapy & IMRT | Nanobiotix | Phase 1/2 | Terminated | 36 |